Product Image

Melatonin Gummies for Kids Strawberry Flavor

NATURELO Premium Supplements
4.6
★ ★ ★ ★ ★
(297 ratings)
Melatonin 1 mg
Product Image
Score79
A low-dose 1 mg gummy designed for gentle sleep-onset support. Pediatric use still calls for individualized guidance and secure storage.
How scoring works
Quantity:60 Gummy(ies) • (60 servings)
Goals:
Sleep Support

Score 79

A low-dose 1 mg gummy designed for gentle sleep-onset support. Pediatric use still calls for individualized guidance and secure storage.
How scoring works
$15.95($0.26 per serving)
iHerb
$ 15.95
Report prices

Analysis

The 1 mg melatonin gummy provides a low, clearly stated amount for circadian timing and sleep onset. A single gummy supplies the serving, which keeps administration simple.

The immediate-release design does not maintain delivery through the night or address relaxation through a second active. Use in children should be individualized with pediatric guidance because sleep problems can have different causes.

The moderate serving cost is reasonable for a child-oriented gummy but not especially low. Secure storage matters because the strawberry candy format can invite unintended use.

Who is it for
  • Families seeking a low-dose gummy after pediatric guidance
  • Children who cannot swallow tablets
  • Users focused on circadian timing
Best for
  • Gentle sleep-onset support
  • One-gummy administration
  • Low-dose melatonin use

Pros

  • Low 1 mg melatonin amount
  • One gummy per serving
  • Clearly disclosed active
  • Easy-to-take format

Cons

  • No sustained overnight release
  • Single-pathway formula
  • Candy-like format needs extra storage care
  • Not a substitute for evaluating persistent sleep problems

Warnings

  • Discuss melatonin use and timing with the child's pediatric clinician
  • Store securely to prevent unintended extra gummies
  • Melatonin may cause morning drowsiness or vivid dreams even at 1 mg

Nutrient quality

86 Highest impact

A low melatonin amount provides conservative dose quality. Candy-like delivery adds low-value material and requires secure storage.

.

Ingredient transparency

84 Highest impact

The active amount and gummy serving are clearly disclosed. Complete directions and the full gummy excipient profile remain absent.

.

Customer satisfaction

69 High impact

Customer sentiment is favorable. A substantial rating base makes the average dependable, while no narrative feedback was supplied.

.

Value for money

72 High impact

Serving economics are weak. Formula quality supports fair practical value.

.
Report analysis

Goals

Sleep Support
Impact
Highest effect
A+ Goal FitA- Strength of SupportC CoverageA Formula Quality
Melatonin · 1 mg

Low-dose melatonin directly supports circadian timing and is well aligned with sleep onset. The single active does not add a separate relaxation or overnight-maintenance pathway.

The one-gummy amount is clear and sits near a cautious starting range. The candy-like format should be stored securely to prevent unintended use, while the streamlined formula avoids unnecessary actives.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Calories
10 Calorie(s)
Total Carbohydrates
2 Gram(s)
Melatonin
1 mg
Adults 18–50 Women Children 4+ Vegetarian
Report overview
Melatonin · 1 mg OverallScore63
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyC Value

The low melatonin dose is well aligned with gentle sleep support and is clearly delivered in one gummy. The gummy should be easy to take, but it is not designed for sustained release and has no stated independent purity certification. Cost per serving is moderate, while the candy-like format should be stored securely to prevent unintended use by children.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
    Salanitro M; Wrigley T; Ghabra H; de Haan E; Hill CM; Solmi M; Cortese S · Neuroscience and biobehavioral reviews · 2022
    Meta-analysis1,998 participants34 studies pooledSleep Support forMelatonin
  3. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  4. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  5. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  6. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  7. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin